Effectiveness of Various Antimicrobial Agents Against Mycobacterium Avium Complex in the Beige Mouse Model

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1994 Nov 1

PMID 7872741

Citations 25

Authors

B Ji

N Lounis

C Truffot-Pernot

J Grosset

Affiliations

Soon will be listed here.

Abstract

The results of five chemotherapeutic experiments in beige mice infected with organisms of the Mycobacterium avium complex are presented. After monotherapy with various antimicrobial agents for 4 weeks, only clarithromycin, amikacin, and ethambutol displayed definite bactericidal effects; sparfloxacin and clofazimine showed modest bacteriostatic effects; and rifampin and rifabutin were totally inactive against the isolate tested. After treatment for 4 weeks, the large quantities of clofazimine that had accumulated in the organs of mice seriously interfered with the enumeration of the CFU and assessment of the efficacy of the treatment. The in vitro synergistic effects of drug combinations against M. avium complex were not confirmed in beige mice. In combination with clarithromycin, amikacin could prevent the selection of clarithromycin-resistant mutants, whereas minocycline could not.

Citing Articles

Regimen comprising clarithromycin, clofazimine and bedaquiline is more efficacious than monotherapy in a mouse model of chronic lung infection.

Rimal B, Howe R, Panthi C, Lamichhane G bioRxiv. 2024; .

PMID: 39713335 PMC: 11661409. DOI: 10.1101/2024.12.11.627976.

An Perspective on What Individual Antimicrobials Add to Mycobacterium avium Complex Therapies.

Sonawane V, Ruth M, Pennings L, Svensson E, Wertheim H, Hoefsloot W Antimicrob Agents Chemother. 2021; 65(8):e0273020.

PMID: 33972258 PMC: 8284439. DOI: 10.1128/AAC.02730-20.

Infection in a C3HeB/FeJ Mouse Model.

Verma D, Stapleton M, Gadwa J, Vongtongsalee K, Schenkel A, Chan E Front Microbiol. 2019; 10:693.

PMID: 31001241 PMC: 6456659. DOI: 10.3389/fmicb.2019.00693.

In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease.

van Ingen J, Totten S, Helstrom N, Heifets L, Boeree M, Daley C Antimicrob Agents Chemother. 2012; 56(12):6324-7.

PMID: 23027189 PMC: 3497179. DOI: 10.1128/AAC.01505-12.

Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis.

Williams K, Minkowski A, Amoabeng O, Peloquin C, Taylor D, Andries K Antimicrob Agents Chemother. 2012; 56(6):3114-20.

PMID: 22470112 PMC: 3370712. DOI: 10.1128/AAC.00384-12.

References

Tsukamura M . In-vitro antimycobacterial activity of minocycline. Tubercle. 1980; 61(1):37-8. DOI: 10.1016/0041-3879(80)90058-6. View

Heifets L . Synergistic effect of rifampin, streptomycin, ethionamide, and ethambutol on Mycobacterium intracellulare. Am Rev Respir Dis. 1982; 125(1):43-8. DOI: 10.1164/arrd.1982.125.1.43. View

Grosset J, Truffot C, Fermanian J, Lecoeur H . [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)]. Pathol Biol (Paris). 1982; 30(6):444-8. View

Zimmer B, DeYoung D, Roberts G . In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex. Antimicrob Agents Chemother. 1982; 22(1):148-50. PMC: 183690. DOI: 10.1128/AAC.22.1.148. View

Cynamon M . Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare. Antimicrob Agents Chemother. 1985; 28(3):440-1. PMC: 180270. DOI: 10.1128/AAC.28.3.440. View

Bertram M, Inderlied C, Yadegar S, Kolanoski P, Yamada J, Young L . Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex. J Infect Dis. 1986; 154(1):194-5. DOI: 10.1093/infdis/154.1.194. View

GANGADHARAM P, Perumal V, Jairam B, Rao P, Nguyen A, Farhi D . Activity of rifabutin alone or in combination with clofazimine or ethambutol or both against acute and chronic experimental Mycobacterium intracellulare infections. Am Rev Respir Dis. 1987; 136(2):329-33. DOI: 10.1164/ajrccm/136.2.329. View

Yajko D, Kirihara J, Sanders C, Nassos P, Hadley W . Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome. Antimicrob Agents Chemother. 1988; 32(9):1392-5. PMC: 175874. DOI: 10.1128/AAC.32.9.1392. View

GANGADHARAM P, Perumal V, Podapati N, Kesavalu L, Iseman M . In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice. Antimicrob Agents Chemother. 1988; 32(9):1400-3. PMC: 175876. DOI: 10.1128/AAC.32.9.1400. View

10.

Inderlied C, Kolonoski P, Wu M, Young L . Amikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige mice. Antimicrob Agents Chemother. 1989; 33(2):176-80. PMC: 171452. DOI: 10.1128/AAC.33.2.176. View

11.

Cynamon M, Swenson C, Palmer G, GINSBERG R . Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice. Antimicrob Agents Chemother. 1989; 33(8):1179-83. PMC: 172620. DOI: 10.1128/AAC.33.8.1179. View

12.

Fernandes P, Hardy D, McDaniel D, Hanson C, SWANSON R . In vitro and in vivo activities of clarithromycin against Mycobacterium avium. Antimicrob Agents Chemother. 1989; 33(9):1531-4. PMC: 172696. DOI: 10.1128/AAC.33.9.1531. View

13.

Franzblau S, White K . Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae. Antimicrob Agents Chemother. 1990; 34(2):229-31. PMC: 171562. DOI: 10.1128/AAC.34.2.229. View

14.

Yajko D, Sanders C, Nassos P, Hadley W . In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin. Antimicrob Agents Chemother. 1990; 34(12):2442-4. PMC: 172081. DOI: 10.1128/AAC.34.12.2442. View

15.

Ji B, Perani E, Grosset J . Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. Antimicrob Agents Chemother. 1991; 35(3):579-81. PMC: 245054. DOI: 10.1128/AAC.35.3.579. View

16.

Truffot-Pernot C, Ji B, Grosset J . Activities of pefloxacin and ofloxacin against mycobacteria: in vitro and mouse experiments. Tubercle. 1991; 72(1):57-64. DOI: 10.1016/0041-3879(91)90025-n. View

17.

Dautzenberg B, Truffot C, Legris S, Meyohas M, Berlie H, Mercat A . Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. Am Rev Respir Dis. 1991; 144(3 Pt 1):564-9. DOI: 10.1164/ajrccm/144.3_Pt_1.564. View

18.

Perronne C, Gikas A, Truffot-Pernot C, Grosset J, Vilde J, Pocidalo J . Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. Antimicrob Agents Chemother. 1991; 35(7):1356-9. PMC: 245171. DOI: 10.1128/AAC.35.7.1356. View

19.

Truffot-Pernot C, Ji B, Grosset J . Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex. Antimicrob Agents Chemother. 1991; 35(8):1677-8. PMC: 245242. DOI: 10.1128/AAC.35.8.1677. View

20.

Klemens S, Cynamon M . In vivo activities of newer rifamycin analogs against Mycobacterium avium infection. Antimicrob Agents Chemother. 1991; 35(10):2026-30. PMC: 245319. DOI: 10.1128/AAC.35.10.2026. View